What is the current Cattle Vaccine market size?

The Cattle Vaccine market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Cattle Vaccine market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driving future outlook.

What are the key drivers of the Cattle Vaccine market?

Increasing disease outbreaks and growing demand for cattle products are key drivers of the market.

What are the major challenges facing the Cattle Vaccine market?

High development costs and strict regulatory requirements are major challenges facing the market.

Which regions are leading the Cattle Vaccine market?

North America and Europe are leading the market due to strong veterinary infrastructure.

Who are the top companies in the Cattle Vaccine market?

Top companies include Zoetis, Merck, and Boehringer Ingelheim, driving market growth.

What future opportunities exist in the Cattle Vaccine market?

Emerging markets and technological advancements present future opportunities for market expansion.

How is technology impacting the Cattle Vaccine market?

Advances in vaccine technology are improving efficacy and driving market growth and future outlook.

What is the current regulatory landscape for the Cattle Vaccine market?

The regulatory landscape is complex, with strict requirements for vaccine approval and distribution.

Cattle Vaccine Market Intelligence Report 2026 — Updated June 2026

Cattle Vaccine by Application (Government Bidding, Market Sales), by Types (Live Attenuated Vaccine, Inactivated Vaccine, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 7.1%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 7.1%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Cattle Vaccine Market Size | CAGR 7.1 Forecast 2033

Cattle Vaccine Market Intelligence Report 2026 — Updated June 2026

🏭 Healthcare🌍 Global

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 7.1%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 7.1%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Cattle Vaccine Market Overview

The Cattle Vaccine market refers to the industry focused on developing and distributing vaccines for cattle to prevent and control diseases. As the animal health industry continues to evolve, the Cattle Vaccine market size is expected to experience significant growth, driven by increasing demand for high-quality animal products and rising concerns over animal health. The growth outlook for the Cattle Vaccine market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of around 5.5% from 2026 to 2033, resulting in an estimated market size of approximately $1.4 billion by 2026. The industry expansion is primarily driven by advancements in vaccine technology, increasing adoption of veterinary vaccines, and growing awareness about animal health.

Loading chart…

The Cattle Vaccine market is shaped by several key forces, including technology shifts towards more effective and safer vaccines, regulations related to animal health and vaccine distribution, and consumer behavior driven by increasing demand for high-quality animal products. The largest region for the Cattle Vaccine market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing adoption of veterinary vaccines and growing awareness about animal health. As the industry continues to evolve, strategic planners and business development teams must stay informed about the latest market trends and insights to make informed decisions and drive business growth.

Report Overview

Report Attribute	Details
Market size value in 2025	8.20 million
Revenue forecast in 2033	14.19 million
Growth rate	CAGR of 7.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck Animal Health https://www.merckanimalhealth.com/; Zoetis https://www.zoetis.com/; Boehringer Ingelheim https://www.boehringer-ingelheim.com/; Ceva https://www.ceva.com/; Jinyu Bio-Technology; CAHIC; TECON
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Cattle Vaccine market is poised for significant growth, driven by increasing demand for high-quality beef and dairy products. This section provides an in-depth analysis of the market dynamics shaping the Cattle Vaccine market size and growth forecast.

Growth Drivers2 items

Advancements in vaccine technology, such as the development of subunit vaccines and recombinant vaccines, are improving the efficacy and safety of cattle vaccines, driving adoption rates among farmers and veterinarians.

Government initiatives and regulations aimed at preventing the spread of diseases, such as bovine tuberculosis and brucellosis, are fueling the demand for cattle vaccines, contributing to the growth of the Cattle Vaccine market.

Restraints2 items

The high cost of developing and manufacturing cattle vaccines, particularly those using advanced technologies, is limiting the market growth, as small-scale farmers and low-income countries may not be able to afford these vaccines.

The complexity of vaccine distribution and storage, particularly in remote areas with limited infrastructure, is hindering the widespread adoption of cattle vaccines, affecting the overall Cattle Vaccine market size.

Opportunities2 items

The increasing demand for cattle vaccines in emerging economies, such as China and India, presents a significant opportunity for market players to expand their presence and drive growth in the Cattle Vaccine market.

The development of novel vaccine delivery systems, such as needle-free injection systems, is expected to improve the efficiency and safety of cattle vaccination, creating new opportunities for market growth and expansion.

Challenges2 items

The risk of vaccine resistance and disease outbreaks poses a significant challenge to the Cattle Vaccine market, as it can lead to decreased efficacy of vaccines and reduced demand.

The intense competition among market players, coupled with the need for continuous innovation and investment in research and development, is a major challenge facing the Cattle Vaccine market, affecting the growth forecast and market dynamics.

Market Segmentation

Loading chart…

The Cattle Vaccine market can be segmented based on Application, which refers to the purpose or use of the vaccine. This segment contributes significantly to the overall Cattle Vaccine market size, as different applications have varying demand and revenue potential. The Application segment includes subtypes such as prevention of diseases, treatment of diseases, and _Cattle Vaccine segmentation_ for maintaining herd health.

Another crucial segment in the Cattle Vaccine market is Types, which encompasses various subtypes of vaccines, including live attenuated vaccines, inactivated vaccines, and subunit vaccines. Each subtype has its unique characteristics, advantages, and market demand, ultimately influencing the overall market size. Understanding these subtypes is essential for market taxonomy, as it enables stakeholders to identify areas of growth and opportunities for innovation.

Cattle Vaccine Segmentation Breakdown7 items

Application

Government Bidding

Market Sales

Types

Live Attenuated Vaccine

Inactivated Vaccine

Others

Regional Insights

Loading chart…

The Cattle Vaccine market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 35% of the market share, and the fastest-growing region, driven by increasing adoption of cattle vaccines, supportive policies, and significant investments in the livestock industry. Key drivers in North America include a mature ecosystem, high infrastructure development, and a strong focus on animal health. In Europe, the market is driven by stringent policies and regulations, a high level of ecosystem maturity, and a growing demand for vaccine products.

In Asia Pacific, the demographics of a large and growing population, coupled with increasing infrastructure development and investments in the agricultural sector, are expected to drive the Cattle Vaccine market growth. Latin America is driven by a growing adoption of cattle vaccines, while the Middle East & Africa region is expected to be driven by government policies and initiatives to improve animal health and prevent disease outbreaks.

Competitive Landscape

The Cattle Vaccine market exhibits a moderately consolidated structure, driven by both global players and local/regional companies. The Cattle Vaccine competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships, while local companies emphasize regional expansion and cost advantages.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. The following companies have distinct strategic focuses:

Merck Animal Health: regional expansion

Zoetis: innovation pipeline

Boehringer Ingelheim: vertical integration

Ceva: premium pricing

Jinyu Bio-Technology: local manufacturing

CAHIC: OEM tie-ups

Key Cattle Vaccine Companies7 items

Merck Animal Health https://www.merckanimalhealth.com/

Zoetis https://www.zoetis.com/

Boehringer Ingelheim https://www.boehringer-ingelheim.com/

Ceva https://www.ceva.com/

Jinyu Bio-Technology

CAHIC

TECON

Market Ecosystem

The Cattle Vaccine ecosystem encompasses a complex network of stakeholders, spanning from upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly divided into three segments: upstream, midstream, and downstream. Upstream participants provide the foundational elements, such as raw materials and technologies, which are then integrated and processed by midstream entities, including manufacturers and system integrators. Finally, downstream channels and end users receive and utilize the final products, creating and capturing value through their interactions.

Raw material/component suppliers — provide vaccine ingredients

OEMs / manufacturers — produce cattle vaccines

Technology providers — offer vaccine development technologies

Distributors / channel partners — facilitate vaccine distribution

End users / buyers — administer vaccines to cattle

Regulators/standards bodies — oversee vaccine safety and efficacy

Service providers / after-sales — support vaccine administration and monitoring

Within the Cattle Vaccine ecosystem, control points and dependency risks significantly influence the adoption and effectiveness of vaccines. Regulators and standards bodies exert control over the approval and distribution of vaccines, while raw material suppliers can impact production through input constraints. Furthermore, the ecosystem's dependency on these participants introduces risks, such as supply chain disruptions and compliance issues. As part of a comprehensive value chain analysis, understanding these dynamics is crucial for navigating the Cattle Vaccine ecosystem, particularly as regional differences in regulations, disease prevalence, and cattle management practices can substantially affect the ecosystem's structure and operations.

Recent Industry Insights

The Cattle Vaccine industry trends have witnessed significant developments over the last 12-18 months, driven by a surge in demand for effective animal health solutions. Recent partnerships between leading pharmaceutical companies and research institutions have focused on developing innovative vaccine platforms. Notable mergers and acquisitions have also taken place, aiming to expand product portfolios and strengthen market presence. Furthermore, several companies have launched new products and technologies, including subunit vaccines and recombinant vaccines, to combat emerging diseases and improve cattle health. Regulatory changes, such as updated guidelines for vaccine efficacy and safety, have also influenced the industry landscape. Additionally, there has been a shift in consumer trends towards more sustainable and animal-friendly farming practices, driving the demand for vaccines that promote animal welfare.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Cattle Vaccine market outlook. The market attractiveness is moderate, driven by increasing demand for high-quality beef and growing concerns about animal health. Competitive intensity is high, with several major players competing for market share. The long-term outlook is positive, with opportunities for growth in emerging markets and innovation in vaccine technology.

The innovation landscape is evolving, with a focus on developing more effective and sustainable vaccines. Demand-supply balance is a key challenge, with fluctuations in supply affecting market stability. Key risk factors include disease outbreaks, regulatory changes, and trade restrictions. Understanding these factors is crucial for decision-makers to navigate the Cattle Vaccine market outlook and make informed investment decisions.

11 items

1. Executive Summary

2. Cattle Vaccine Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Cattle Vaccine Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Cattle Vaccine Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Government Bidding

6.1.2. Market Sales

6.2. Global Cattle Vaccine Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Live Attenuated Vaccine

6.2.2. Inactivated Vaccine

6.2.3. Others

6.3. Global Cattle Vaccine Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Cattle Vaccine Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Cattle Vaccine Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Cattle Vaccine Market Competition by Key Manufacturers

8.1. Global Cattle Vaccine Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Cattle Vaccine: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Merck Animal Health https://www.merckanimalhealth.com/

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Zoetis https://www.zoetis.com/

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Boehringer Ingelheim https://www.boehringer-ingelheim.com/

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Ceva https://www.ceva.com/

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Jinyu Bio-Technology

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. CAHIC

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. TECON

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Cattle Vaccine Market

Figure 4: Global Cattle Vaccine Market: Drivers

Figure 5: Global Cattle Vaccine Market: Challenges

Figure 6: Global Cattle Vaccine Market: Trends

Figure 7: Global Cattle Vaccine Market: Opportunity

Figure 8: Global Cattle Vaccine Market: Restraint

Figure 9: Global Cattle Vaccine Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Cattle Vaccine Market Value (USD Million) By Region

Figure 15: Global Cattle Vaccine Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Cattle Vaccine Market Value (USD Million) By Region

Figure 23: Global Cattle Vaccine Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Cattle Vaccine Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Cattle Vaccine Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Cattle Vaccine Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Cattle Vaccine Market Value (USD Million) By Region

Table 10: Global Cattle Vaccine Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Cattle Vaccine Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Cattle Vaccine Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Cattle Vaccine Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Merck Animal Health https://www.merckanimalhealth.com/ Basic Information And Sales Area

Table 31: Merck Animal Health https://www.merckanimalhealth.com/. Products Portfolio

Table 32: Zoetis https://www.zoetis.com/ Basic Information And Sales Area

Table 33: Zoetis https://www.zoetis.com/. Products Portfolio

Table 34: Boehringer Ingelheim https://www.boehringer-ingelheim.com/ Basic Information And Sales Area

Table 35: Boehringer Ingelheim https://www.boehringer-ingelheim.com/. Products Portfolio

Table 36: Ceva https://www.ceva.com/ Basic Information And Sales Area

Table 37: Ceva https://www.ceva.com/. Products Portfolio

Table 38: Jinyu Bio-Technology Basic Information And Sales Area

Table 39: Jinyu Bio-Technology. Products Portfolio

Table 40: CAHIC Basic Information And Sales Area

Table 41: CAHIC. Products Portfolio

Table 42: TECON Basic Information And Sales Area

Table 43: TECON. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global Cattle Vaccine Market Value (USD Million) By Region

Table 49: Global Cattle Vaccine Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Cattle Vaccine Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.20 million
Revenue forecast in 2033	14.19 million
Growth rate	CAGR of 7.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck Animal Health https://www.merckanimalhealth.com/; Zoetis https://www.zoetis.com/; Boehringer Ingelheim https://www.boehringer-ingelheim.com/; Ceva https://www.ceva.com/; Jinyu Bio-Technology; CAHIC; TECON
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options